Display options
Share it on

Mol Cell Biochem. 2010 Nov;344(1):185-93. doi: 10.1007/s11010-010-0541-3. Epub 2010 Jul 31.

Molecular susceptibility to glycation and its implication in diabetes mellitus and related diseases.

Molecular and cellular biochemistry

José D Méndez, Jianling Xie, Montserrat Aguilar-Hernández, Verna Méndez-Valenzuela

Affiliations

  1. Medical Research Unit in Metabolic Diseases, National Medical Center, Mexican Institute of Social Security, Mexico, DF, Mexico. [email protected]

PMID: 20680411 DOI: 10.1007/s11010-010-0541-3

Abstract

The modification of free amino groups on proteins, lipids, and nucleic acids by non-enzymatic glycosylation produce a variety of complex structures named advanced glycation end products (AGEs). Glycation of these molecules participate in the development of diabetic complications and related diseases. Diabetes mellitus is characterized by short-term metabolic changes in lipid and protein metabolism, and long-term irreversible changes in vascular and connective tissue. AGEs are directly implicated in the development of chronic complications in diabetes such as nephropathy, rethinopathy, neuropathy, and other related diseases such as atherosclerosis, heart disease, stroke, and peripheral vascular disease. In this review, we aim to explain how glycation occurs in different molecules and what the pathological consequence of AGE formation in diabetes mellitus and other diseases are.

References

  1. Diabetes Metab Rev. 1987 Apr;3(2):463-524 - PubMed
  2. Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9441-5 - PubMed
  3. Sci Am. 1978 Dec;239(6):92-125 - PubMed
  4. Diabetologia. 1991 Jun;34(6):387-9 - PubMed
  5. Arch Biochem Biophys. 1991 Aug 1;288(2):473-80 - PubMed
  6. Adv Pharmacol. 1992;23:1-34 - PubMed
  7. N Engl J Med. 1971 Feb 18;284(7):353-7 - PubMed
  8. J Biol Chem. 1983 Aug 10;258(15):9406-12 - PubMed
  9. FEBS Lett. 1974 Jan 15;38(3):247-58 - PubMed
  10. Biochim Biophys Acta. 1971 Jan 19;229(1):42-50 - PubMed
  11. Diabetes. 1995 Jan;44(1):20-4 - PubMed
  12. Acta Ophthalmol (Copenh). 1994 Oct;72(5):553-9 - PubMed
  13. N Engl J Med. 1981 Jul 30;305(5):237-42 - PubMed
  14. J Biol Chem. 1981 May 25;256(10):5176-80 - PubMed
  15. Diabetes. 1986 Aug;35(8):916-21 - PubMed
  16. Diabetologia. 2000 Aug;43(8):957-73 - PubMed
  17. Bioorg Med Chem Lett. 1998 Aug 18;8(16):2109-10 - PubMed
  18. Science. 1981 Jul 10;213(4504):222-4 - PubMed
  19. Science. 1978 Apr 7;200(4337):21-7 - PubMed
  20. FASEB J. 1992 Aug;6(11):2905-14 - PubMed
  21. Arch Biochem Biophys. 1995 Jan 10;316(1):547-54 - PubMed
  22. J Chromatogr B Biomed Sci Appl. 2001 Jul 5;758(1):109-15 - PubMed
  23. Circ Res. 2004 Apr 16;94(7):976-83 - PubMed
  24. J Biol Chem. 1978 Apr 10;253(7):2327-32 - PubMed
  25. Ann Clin Biochem. 1986 Mar;23 ( Pt 2):198-203 - PubMed
  26. Ann Intern Med. 1984 Oct;101(4):527-37 - PubMed
  27. Eur J Clin Invest. 1997 Feb;27(2):97-108 - PubMed
  28. Arch Biochem Biophys. 2010 Jan 15;493(2):192-206 - PubMed
  29. Curr Atheroscler Rep. 2000 Sep;2(5):430-6 - PubMed
  30. Nat Med. 1995 Oct;1(10):1057-61 - PubMed
  31. N Engl J Med. 1976 Aug 19;295(8):443-4 - PubMed
  32. J Diabetes Complications. 2004 Mar-Apr;18(2):129-40 - PubMed
  33. J Clin Invest. 1995 May;95(5):2338-45 - PubMed
  34. Clin Chem. 1983 Feb;29(2):340-3 - PubMed
  35. Arch Biochem Biophys. 1992 Apr;294(1):130-7 - PubMed
  36. J Lipid Res. 2003 Mar;44(3):487-93 - PubMed
  37. Annu Rev Biochem. 1981;50:385-432 - PubMed
  38. Nature. 1988 Feb 25;331(6158):725-8 - PubMed
  39. Lancet. 1996 Feb 24;347(9000):513-5 - PubMed
  40. Lancet. 1980 Apr 5;1(8171):738-40 - PubMed
  41. Biochemistry. 1995 Jan 17;34(2):648-55 - PubMed
  42. Diabetes. 1983 Jul;32(7):670-4 - PubMed
  43. Nucleic Acids Symp Ser. 1982;(11):281-4 - PubMed
  44. Biomed Pharmacother. 2007 Dec;61(10):693-7 - PubMed
  45. J Exp Med. 1984 Jul 1;160(1):197-207 - PubMed
  46. Annu Rev Med. 1995;46:223-34 - PubMed
  47. N Engl J Med. 1984 Feb 9;310(6):356-60 - PubMed
  48. Science. 1996 May 3;272(5262):699-700 - PubMed
  49. Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6434-8 - PubMed
  50. Proc Natl Acad Sci U S A. 1982 Nov;79(21):6546-50 - PubMed
  51. Ann Intern Med. 1989 May 15;110(10):795-813 - PubMed
  52. Cancer Res. 1982 Apr;42(4):1286-8 - PubMed
  53. J Mol Biol. 1984 May 15;175(2):159-74 - PubMed
  54. Biochem J. 1999 Nov 15;344 Pt 1:109-16 - PubMed
  55. J Biol Chem. 1980 Apr 10;255(7):3120-7 - PubMed
  56. Nurs Stand. 2008 Mar 12-18;22(27):51-7; quiz 58, 60 - PubMed
  57. Bioorg Med Chem Lett. 1998 Aug 4;8(15):2017-22 - PubMed
  58. J Biol Chem. 1992 May 25;267(15):10211-4 - PubMed
  59. FEBS Lett. 2008 Jun 11;582(13):1783-7 - PubMed
  60. Biochim Biophys Acta. 2009 Oct;1790(10):1109-16 - PubMed
  61. Curr Diab Rep. 2004 Feb;4(1):31-6 - PubMed
  62. Diabetologia. 2001 Feb;44(2):129-46 - PubMed
  63. Cell Mol Biol (Noisy-le-grand). 1998 Nov;44(7):1129-38 - PubMed
  64. Biochem Biophys Res Commun. 1995 Jul 6;212(1):56-62 - PubMed
  65. Diabetologia. 1983 Dec;25(6):496-501 - PubMed
  66. Diabetes. 1979 Apr;28(4):337-40 - PubMed
  67. J Diabetes Complications. 2002 Jul-Aug;16(4):284-93 - PubMed
  68. Kidney Int. 1992 Oct;42(4):875-81 - PubMed
  69. Int Rev Neurobiol. 2002;50:37-57 - PubMed
  70. J Biol Chem. 1986 Oct 15;261(29):13542-5 - PubMed
  71. Biochim Biophys Acta. 1989 Jul 17;1004(1):1-19 - PubMed
  72. Exp Eye Res. 1992 Mar;54(3):337-45 - PubMed
  73. Clin Chim Acta. 1983 Jan 7;127(1):87-95 - PubMed
  74. N Engl J Med. 1976 Aug 19;295(8):417-20 - PubMed
  75. Diabetes. 1989 Dec;38(12):1539-43 - PubMed
  76. Science. 1981 Jan 30;211(4481):491-3 - PubMed

Substances

MeSH terms

Publication Types